Alnylam Pharmaceuticals, Inc.
Records under this name other than the patents Alnylam Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 308 patents it holds.
Back to Alnylam Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,956,177 | Dsrna Compositions and Methods for Treating HPV Infection now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 8,642,076 | Lipid Containing Formulations now held by Arbutus Biopharma Corporation In force · Low confidence | In force | Low confidence | |
| US 7,888,498 | Compositions and Methods for Inhibiting Expression of Ikk-B Gene In force · High confidence | In force | High confidence | |
| US 9,814,777 | Targeting Lipids conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,148,344 | Compositions and Methods for Mediating Rnai in Vivo now held by Eth Zurich In force · High confidence | In force | High confidence | |
| US 8,324,366 | Compositions and Methods for Delivering Rnai Using Lipoproteins now held by Eth Zurich In force · High confidence | In force | High confidence | |
| US 8,722,082 | Lipids and Compositions for the Delivery of Therapeutics now held by Arbutus Biopharma Corporation In force · High confidence | In force | High confidence | |
| US 9,707,292 | Novel Lipids and Compositions for the Delivery of Therapeutics conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation In force · High confidence | In force | High confidence | |
| US 9,764,036 | Novel Lipids and Compositions for the Delivery of Therapeutics conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation In force · High confidence | In force | High confidence | |
| US 10,117,941 | Novel Lipids and Compositions for the Delivery of Therapeutics conveyed to Tekmira Pharmaceuticals Corporation - now held by Arbutus Biopharma Corporation Grace period ended · Low confidence | Grace period ended | Low confidence |